Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | WRN | Q14191 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | MGAM | O43451 | 1/20 | 0.41 |
| ▸ | SI | P14410 | 1/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.41 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13294860 | 0.89 | NAAA (0.41) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL447535 | 0.88 | — | — | |
| SCHEMBL681192 | 0.87 | NAAA (0.52) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| Methane SCHEMBL6300031 | 0.84 | NAAA (0.50) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL8445643 | 0.84 | NAAA (0.52) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL448527 | 0.84 | NAAA (0.52) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL19821316 | 0.82 | ALDH1A1 (0.46) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL14535001 | 0.82 | TDP1 (0.41) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL31516165 | 0.80 | NAAA (0.43) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL16616581 | 0.80 | NAAA (0.43) | NAAAALDH1A1CYP1A2HPGDCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106470968-B | Process for preparing 1,1-disubstituted ethylene monomers | 艾费尼蒂卡科技有限公司 | 2020-05-12 | — | — | CN | claimed |
| EP-3126321-B1 | PROCESS FOR PREPARING 1,1-DISUBSTITUTED ETHYLENE MONOMERS | AFINITICA TECH S L (ES) | 2018-03-07 | — | — | EP | claimed |
| US-9670145-B2 | Process for preparing 1,1-disubstituted ethylene monomers | AFINITICA TECHNOLOGIES, S. L. (ES) | 2017-06-06 | — | — | US | claimed |
| CN-106470968-A | The method preparing 1,1 disubstituted vinyl monomers | 艾费尼蒂卡科技有限公司 | 2017-03-01 | — | — | CN | claimed |
| EP-3126321-A1 | PROCESS FOR PREPARING 1,1-DISUBSTITUTED ETHYLENE MONOMERS | Afinitica Technologies, S. L. (ES) | 2017-02-08 | — | — | EP | claimed |
| US-20170022151-A1 | PROCESS FOR PREPARING 1,1-DISUBSTITUTED ETHYLENE MONOMERS | AFINITICA TECHNOLOGIES, S. L. (ES) | 2017-01-26 | — | — | US | claimed |
| WO-2015150882-A1 | PROCESS FOR PREPARING 1,1-DISUBSTITUTED ETHYLENE MONOMERS | AFINITICA TECHNOLOGIES, S. L. (ES) | 2015-10-08 | — | — | WO | claimed |
| EP-2927209-A1 | Process for preparing 1,1-disubstituted ethylenic monomers | Afinitica Technologies, S. L. (ES) | 2015-10-07 | — | — | EP | claimed |
| US-20250304529-A1 | BIOBASED CYANOACRYLATE COMPOUND | BOSTIK SA (FR) | 2025-10-02 | — | — | US | disclosed |
| EP-4532465-A1 | BIOBASED CYANOACRYLATE COMPOUND | Bostik SA (FR) | 2025-04-09 | — | — | EP | disclosed |
| CN-119451941-A | Bio-based cyanoacrylate compounds | 博斯蒂克股份公司 | 2025-02-14 | — | — | CN | disclosed |
| WO-2023232948-A1 | BIOBASED CYANOACRYLATE COMPOUND | BOSTIK SA (FR) | 2023-12-07 | — | — | WO | disclosed |
| EP-4286369-A1 | BIOBASED CYANOACRYLATE COMPOUND | Bostik SA (FR) | 2023-12-06 | — | — | EP | disclosed |
| EP-3126321-B1 | PROCESS FOR PREPARING 1,1-DISUBSTITUTED ETHYLENE MONOMERS | AFINITICA TECH S L (ES) | 2018-03-07 | — | — | EP | disclosed |
| WO-2015150882-A1 | PROCESS FOR PREPARING 1,1-DISUBSTITUTED ETHYLENE MONOMERS | AFINITICA TECHNOLOGIES, S. L. (ES) | 2015-10-08 | — | — | WO | disclosed |
| EP-2927209-A1 | Process for preparing 1,1-disubstituted ethylenic monomers | Afinitica Technologies, S. L. (ES) | 2015-10-07 | — | — | EP | disclosed |
| EP-2927209-A1 | Process for preparing 1,1-disubstituted ethylenic monomers | Afinitica Technologies, S. L. (ES) | 2015-10-07 | — | — | EP | disclosed |
| US-4123552-A | FUNGICIDES | CHEVRON RESEARCH COMPANY (US) | 1978-10-31 | — | — | US | disclosed |
| US-4012526-A | Oxymethylene di-carboxylic acid esters as anti-fungal agents and animal growth promoters | CHEVRON RESEARCH COMPANY (US) | 1977-03-15 | — | — | US | disclosed |
| US-3931412-A | Fungus and bacteria control with di-carboxylic acid esters | CHEVRON RESEARCH COMPANY (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250304529-A1 | BIOBASED CYANOACRYLATE COMPOUND | BAP1, CBR1, CBR3 | NAAA 1353/4885ALDH1A1 95/4885CYP1A2 853/4885 |
| US-20170022151-A1 | PROCESS FOR PREPARING 1,1-DISUBSTITUTED ETHYLENE MONOMERS | ESD, AP1M1, SULT1A1 | NAAA 1447/4885ALDH1A1 62/4885CYP1A2 1107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.